HF
CRBP icon

HRT Financial’s Corbus Pharmaceuticals CRBP Stock Holding History

HRT Financial’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,660
Closed -$175K – 4374
2026
Q1 		$175K Buy
+18,660
New +$157K ﹤0.01% 3232
2025
Q3 		– Sell
-11,548
Closed -$79K – 2970
2025
Q2 		$79K Buy
+11,548
New +$83.9K ﹤0.01% 2245
2025
Q1 		– Sell
-10,314
Closed -$121K – 2637
2024
Q4 		$121K Sell
10,314
-14,250
-58% -$239K ﹤0.01% 2021
2024
Q3 		$506K Buy
+24,564
New +$1.26M ﹤0.01% 1585
2024
Q2 		– Sell
-12,314
Closed -$483K – 2347
2024
Q1 		$483K Buy
+12,314
New +$304K ﹤0.01% 1277
2022
Q3 		– Sell
-877
Closed -$6K – 2903
2022
Q2 		$6K Buy
+877
New +$8.48K ﹤0.01% 2724
2021
Q4 		– Sell
-5,874
Closed -$179K – 3315
2021
Q3 		$179K Buy
5,874
+4,385
+294% +$173K ﹤0.01% 2731
2021
Q2 		$81K Sell
1,489
-2,473
-62% -$137K ﹤0.01% 2622
2021
Q1 		$234K Sell
3,962
-25,488
-87% -$1.68M ﹤0.01% 2235
2020
Q4 		$1.1M Buy
29,450
+26,246
+819% +$981K 0.02% 573
2020
Q3 		$172K Buy
+3,204
New +$580K 0.01% 1405

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

HRT Financial's CRBP Position: Q2 2026 in Review

HRT Financial sold out of Corbus Pharmaceuticals (CRBP) in Q2 2026, closing a stake of 18,660 shares — an estimated $175K sold.

HRT Financial first reported a position in CRBP in Q3 2020 and held it in 11 quarters. The position peaked at $1.1M in Q4 2020. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • HRT Financial reported no remaining Corbus Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 18,660 Corbus Pharmaceuticals shares in Q2 2026, an estimated $175K.
  • HRT Financial first reported a position in Corbus Pharmaceuticals in Q3 2020 and held it in 11 quarters.
  • HRT Financial's Corbus Pharmaceuticals position peaked at $1.1M in Q4 2020.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.